This is to inform you that pursuant to Regulation 30 and Regulation 33 of the Listing Regulations, the Board at its meeting held today i.e., Friday, May 29, 2026, through video Conferencing, ....
Awaiting price reaction for this filing.
Garodia Chemicals Ltd's Board approved the audited financial results for Q4 and FY ended March 31, 2026. The company reported total revenue of Rs. 405.88 lakhs (all from other income related to settlement of loans from related parties under NCLT's Base Resolution Plan). Profit before tax for FY26 was Rs. 391.67 lakhs, a significant turnaround from a loss of Rs. 20.77 lakhs in FY25. As part of a capital reorganization approved by NCLT, the company's share capital was reduced from 72 lakh shares to 2.63 lakh shares, and 50 lakh new shares were allotted to a new promoter. The accumulated losses of Rs. 7.17 crores were partially written off. EPS has been restated for all periods due to this capital reorganization. Statutory auditors Laxmikant Kabra & Co LLP issued an unmodified opinion.
The company has swung from loss to profit due to one-time income from loan settlements. The capital reorganization drastically reduced share capital and brought in a new promoter. Shareholders should note the EPS restatement and that operational revenue appears minimal.